Matches in SemOpenAlex for { <https://semopenalex.org/work/W4288431727> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W4288431727 abstract "Abstract It was recently demonstrated that newly invented positronium imaging may be used for improving cancer diagnostics by providing additional information about tissue pathology with respect to the standardized uptake value currently available in positron emission tomography (PET). Positronium imaging utilizes the properties of positronium atoms, which are built from the electron and positron produced in the body during PET examinations. We hypothesized whether positronium imaging would be sensitive to in vitro discrimination of tumor-like three-dimensional structures (spheroids) built of melanoma cell lines with different cancer activity and biological properties. The lifetime of ortho-Positronium (o-Ps) was evaluated in melanoma spheroids from two cell lines (WM266-4 and WM115) differing in the stage of malignancy. Additionally, we considered such parameters: as cell size, proliferation rate and malignancy to evaluate their relationship with o-Ps lifetime. We demonstrate the pilot results for the o-Ps lifetime measurement in extracellular matrix free spheroids. With the statistical significance of two standard deviations, we demonstrated that the higher the degree of malignancy and the rate of proliferation of neoplastic cells the shorter the lifetime of ortho-positronium. In particular we observed following indications encouraging further research: (i) WM266-4 spheroids characterized by higher proliferation rate and malignancy showed shorter o-Ps lifetime compared to WM115 spheroids characterized by the lower growth rate, (ii) Both cell lines showed a decrease in the lifetime of o-Ps after spheroid generation in 8th day comparing to 4th day in culture and the mean o-Ps lifetime is longer for spheroids formed from WM115 cells than these from WM266-4 cells, regardless spheroid age. The results of this study revealed that positronium is a promising biomarker that may be applied in PET diagnostics for the assessment of the degree of cancer malignancy." @default.
- W4288431727 created "2022-07-29" @default.
- W4288431727 creator A5000624464 @default.
- W4288431727 creator A5082686750 @default.
- W4288431727 creator A5090813957 @default.
- W4288431727 date "2022-07-28" @default.
- W4288431727 modified "2023-10-18" @default.
- W4288431727 title "3D melanoma spheroid model for the development of positronium biomarker" @default.
- W4288431727 doi "https://doi.org/10.21203/rs.3.rs-1774434/v1" @default.
- W4288431727 hasPublicationYear "2022" @default.
- W4288431727 type Work @default.
- W4288431727 citedByCount "0" @default.
- W4288431727 crossrefType "posted-content" @default.
- W4288431727 hasAuthorship W4288431727A5000624464 @default.
- W4288431727 hasAuthorship W4288431727A5082686750 @default.
- W4288431727 hasAuthorship W4288431727A5090813957 @default.
- W4288431727 hasBestOaLocation W42884317271 @default.
- W4288431727 hasConcept C121332964 @default.
- W4288431727 hasConcept C142724271 @default.
- W4288431727 hasConcept C147120987 @default.
- W4288431727 hasConcept C154726568 @default.
- W4288431727 hasConcept C175369904 @default.
- W4288431727 hasConcept C185544564 @default.
- W4288431727 hasConcept C185592680 @default.
- W4288431727 hasConcept C192562407 @default.
- W4288431727 hasConcept C202100949 @default.
- W4288431727 hasConcept C202751555 @default.
- W4288431727 hasConcept C2775842073 @default.
- W4288431727 hasConcept C2777658100 @default.
- W4288431727 hasConcept C2779399171 @default.
- W4288431727 hasConcept C2989005 @default.
- W4288431727 hasConcept C502942594 @default.
- W4288431727 hasConcept C55493867 @default.
- W4288431727 hasConcept C62112901 @default.
- W4288431727 hasConcept C71924100 @default.
- W4288431727 hasConceptScore W4288431727C121332964 @default.
- W4288431727 hasConceptScore W4288431727C142724271 @default.
- W4288431727 hasConceptScore W4288431727C147120987 @default.
- W4288431727 hasConceptScore W4288431727C154726568 @default.
- W4288431727 hasConceptScore W4288431727C175369904 @default.
- W4288431727 hasConceptScore W4288431727C185544564 @default.
- W4288431727 hasConceptScore W4288431727C185592680 @default.
- W4288431727 hasConceptScore W4288431727C192562407 @default.
- W4288431727 hasConceptScore W4288431727C202100949 @default.
- W4288431727 hasConceptScore W4288431727C202751555 @default.
- W4288431727 hasConceptScore W4288431727C2775842073 @default.
- W4288431727 hasConceptScore W4288431727C2777658100 @default.
- W4288431727 hasConceptScore W4288431727C2779399171 @default.
- W4288431727 hasConceptScore W4288431727C2989005 @default.
- W4288431727 hasConceptScore W4288431727C502942594 @default.
- W4288431727 hasConceptScore W4288431727C55493867 @default.
- W4288431727 hasConceptScore W4288431727C62112901 @default.
- W4288431727 hasConceptScore W4288431727C71924100 @default.
- W4288431727 hasLocation W42884317271 @default.
- W4288431727 hasLocation W42884317272 @default.
- W4288431727 hasOpenAccess W4288431727 @default.
- W4288431727 hasPrimaryLocation W42884317271 @default.
- W4288431727 hasRelatedWork W1450381943 @default.
- W4288431727 hasRelatedWork W1600563716 @default.
- W4288431727 hasRelatedWork W179950665 @default.
- W4288431727 hasRelatedWork W1872310143 @default.
- W4288431727 hasRelatedWork W2027348061 @default.
- W4288431727 hasRelatedWork W2070860962 @default.
- W4288431727 hasRelatedWork W2167241115 @default.
- W4288431727 hasRelatedWork W2478456598 @default.
- W4288431727 hasRelatedWork W2489539655 @default.
- W4288431727 hasRelatedWork W44395262 @default.
- W4288431727 isParatext "false" @default.
- W4288431727 isRetracted "false" @default.
- W4288431727 workType "article" @default.